[Clinical significance of prostaglandins and other arachidonic acid metabolites. Prostacyclin (PGI2), thromboxane A2, leukotriene].
D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001095:Arachidonic Acids / Q000378:metabolism*; D011464:Epoprostenol / Q000502:physiology*; D005767:Gastrointestinal Diseases / Q000209:etiology; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D008171:Lung Diseases / Q000209:etiology; D009369:Neoplasms / Q000209:etiology; D011453:Prostaglandins / Q000378:metabolism / Q000502:physiology* / Q000627:therapeutic use; D013189:SRS-A / Q000502:physiology*; D013928:Thromboxane A2 / Q000502:physiology*; D013931:Thromboxanes / Q000502:physiology*; D014652:Vascular Diseases / Q000209:etiology
D000893:Anti-Inflammatory Agents; D001095:Arachidonic Acids; D011453:Prostaglandins; D013189:SRS-A; D013931:Thromboxanes; D013928:Thromboxane A2; D011464:Epoprostenol
Die klinische Bedeutung der Prostaglandine und anderer Arachidonsäuremetaboliten. Prostazyklin (PGI2), Thromboxan A2, Leukotriene.